期刊文献+

结直肠癌中ERCC1蛋白的表达与预后生存关系的Meta分析 被引量:1

ERCC1 expression and its prognosis implication in colorectal cancer:a meta-analysis
下载PDF
导出
摘要 目的评价结直肠癌患者中核苷酸切除修复交叉互补酶1(ERCC1)蛋白的表达与患者预后的相关性进行meta分析。方法采用计算机检索,检索范围包括全文数据库(CNKI),万方数据库,PubMed、Embase和ASCO数据库。收集比较不同核苷酸切除修复交叉互补酶1蛋白表达水平的结直肠癌患者预后相关的文章,采用revman软件,对文献进行Meta分析。结果最终纳入5项研究,对纳入的文献进行异质性检验显示P=0.14,异质性不大,ERCC1蛋白阴性表达的患者的死亡率低于ERCC1阳性的患者,合并相对危险比RR=0.56;95%可信区间0.37~0.86。结论结直肠癌中ERCC1蛋白阴性的患者预后较ERCC1阳性者好。 Objective To evaluate the relationship between ERCClprotein expression and its prognostic implication in colorectal caner patients. Methods All the data dealing with the relationship between ER- CClexpression and the prognosis of colorectal cancer was researched from PubMed,Embase, ASCO, CNKI and WANFANG. Database. Meta-analysis was conducted by the Stata software. Results We finally identi- fied 5 studies. The test for heterogeneity showed that all eligible studies were with no clear heterogeneity ( P =0.08). The relative risk (RR) was 0. 765, with 95% confidence interval of 0. 62~0.95. Conclusion Compared to patients with negative ERCC1 protein expression, the patient with positive ERCC1 protein expression in colorectal cancer showed poor prognosis.
出处 《结直肠肛门外科》 2012年第3期162-165,共4页 Journal of Colorectal & Anal Surgery
关键词 ERCC1 结直肠癌 META分析 预后 Colorectal cancer ERCCl Prognosis Meta analysis
  • 相关文献

参考文献6

二级参考文献56

  • 1刘国艳,瞿全新,糜若然,齐静.RNA干扰技术抑制切除修复交叉互补基因1对卵巢上皮性癌细胞顺铂敏感性的影响[J].中华妇产科杂志,2006,41(5):339-342. 被引量:20
  • 2周彩存,徐妍,苏春霞,邓沁芳,陈晓峰,易祥华.ERCC1在非小细胞肺癌中表达及其临床意义[J].中国癌症杂志,2006,16(8):622-625. 被引量:23
  • 3逯晓波,安春丽,Tahar Van Der Straaten,董光辉.ERCC1蛋白表达及对草酸铂细胞毒作用影响[J].中国公共卫生,2007,23(2):206-207. 被引量:3
  • 4肖永营,宋勇,施毅,印洪林,周晓军.非小细胞肺癌患者ERCC1蛋白表达与铂类标准方案化疗敏感性的关系研究[J].临床肿瘤学杂志,2007,12(5):339-342. 被引量:8
  • 5Siddik Z H.Cisplatin:mode of cytotoxic action and molecular basis of resistance[J].Oncogene,2003,22(47):7265-7279.
  • 6Zhou W,Gurubhagavatula S,Liu G,et al.Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy[J].Clin Cancer Res,2004,10(15):4939-4943.
  • 7Khan M S,Dodson A R,Heatley M K,et al.Oestrogen receptor,and progesterone receptor proteins in the human rete ovarii and in endometriosis[J].Clin Pathol,1999,52(7):517-520.
  • 8Tripsianes K,Folkers G E,Zheng C,et al.Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization[J].Nucleic Acids Res,2007,35(17):5789-5798.
  • 9Rosell R,Lord R V,Taron M,et al.DNA repair and cisplatin resistance in non-small-cell lung cancer[J].Lung Cancer,2002,38(3):217-227.
  • 10Gustavsson B,Kaiser C,Carlsson G,et al.Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer:mRNA expression for 18 chemotherapy-related genes[J].Int J Cancer,2009,124(5):1220-1226.

共引文献44

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部